CJC-1295 with DAC

CJC-1295 with DAC is a long-acting growth hormone-releasing hormone analogue designed with a Drug Affinity Complex that can associate with circulating albumin and extend exposure. It is studied in endocrine research involving growth-hormone secretion, IGF-1 signaling, pharmacokinetics, receptor activation and feedback regulation of the hypothalamic-pituitary axis. The extended-duration design makes it useful for comparing short- and long-acting GHRH analogues, evaluating exposure-response relationships and measuring sustained biomarker changes. Researchers should confirm that the supplied material is specifically the DAC-containing version, since non-DAC CJC analogues differ in pharmacokinetic behavior. Experimental outcomes depend on model, dose concentration, sampling schedule and analytical purity.

For laboratory research use only. Not for human or veterinary use. This description is informational and does not provide medical advice, dosing, or treatment guidance.